baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VM69DM0 /

2024-06-28 9:41:43 PM	Chg.-0.27	Bid9:59:58 PM	Ask9:59:58 PM	Underlying	Strike price	Expiration date	Option type
4.60EUR	-5.54%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	160.10 USD	2078-12-31	Call

GlobeNewswire 06-28 Rocky Mountain Chocolate Factory Appoints Charles B. Arnold to Its Board of Directors and Audit Comm...

GlobeNewswire 06-28 Tiziana Receives $3.4 Million in Non-Dilutive Funding

GlobeNewswire 06-28 KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid My...

GlobeNewswire 06-28 Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle a...

GlobeNewswire 06-28 Eyenovia Announces Pricing of $5M Registered Direct Offering

GlobeNewswire 06-28 Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...

GlobeNewswire 06-28 Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographi...

GlobeNewswire 06-28 XPPen to Showcase Diverse Innovative Products at Anime Expo 2024

GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...

GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...

GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...

GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...

GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients

GlobeNewswire 06-14 Progressive Reports May 2024 Results

GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 06-09 EP updated results, EPP with 189 seats

BVT Knock-Out PGR/ DE000VM69DM0 /

If you wish to receive reply to your feedback, please provide your email address.